Aqr Capital Management LLC Syndax Pharmaceuticals Inc Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Aqr Capital Management LLC holds 25,419 shares of SNDX stock, worth $347,986. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,419

Previous 27,273 6.8%

Holding current value

$347,986

Previous $559,000 12.52%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$17.93 - $24.81 $33,242 - $45,997	-1,854 Reduced 6.8%	25,419 $489,000
Q2 2024 Aug 14, 2024	SELL	$18.82 - $23.79 $488,247 - $617,183	-25,943 Reduced 48.75%	27,273 $559,000
Q1 2024 May 15, 2024	BUY	$19.71 - $24.57 $341,258 - $425,404	17,314 Added 48.23%	53,216 $1.27 Million
Q4 2023 Feb 14, 2024	BUY	$11.39 - $21.67 $129,048 - $245,521	11,330 Added 46.11%	35,902 $775,000
Q3 2023 Nov 14, 2023	BUY	$14.52 - $21.77 $44,053 - $66,050	3,034 Added 14.09%	24,572 $356,000
Q2 2023 Aug 14, 2023	SELL	$19.35 - $22.31 $32,701 - $37,703	-1,690 Reduced 7.28%	21,538 $450,000
Q1 2023 May 15, 2023	SELL	$20.66 - $28.98 $40,225 - $56,424	-1,947 Reduced 7.73%	23,228 $490,000
Q4 2022 Feb 14, 2023	BUY	$20.64 - $26.24 $66,997 - $85,175	3,246 Added 14.8%	25,175 $640,000
Q3 2022 Nov 14, 2022	SELL	$18.51 - $24.79 $248,570 - $332,904	-13,429 Reduced 37.98%	21,929 $527,000
Q2 2022 Aug 15, 2022	BUY	$13.64 - $19.48 $158,319 - $226,104	11,607 Added 48.87%	35,358 $680,000
Q1 2022 May 16, 2022	BUY	$14.84 - $22.15 $352,464 - $526,084	23,751 New	23,751 $413,000
Q2 2021 Aug 16, 2021	SELL	$13.42 - $25.18 $250,685 - $470,362	-18,680 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$19.28 - $24.59 $217,536 - $277,448	-11,283 Reduced 37.66%	18,680 $418,000
Q4 2020 Feb 16, 2021	SELL	$15.1 - $26.44 $195,877 - $342,979	-12,972 Reduced 30.21%	29,963 $666,000
Q3 2020 Nov 16, 2020	SELL	$13.39 - $17.48 $25,079 - $32,740	-1,873 Reduced 4.18%	42,935 $634,000
Q2 2020 Aug 17, 2020	BUY	$8.94 - $20.98 $304,666 - $714,977	34,079 Added 317.63%	44,808 $664,000
Q1 2020 May 15, 2020	BUY	$6.65 - $12.03 $71,347 - $129,069	10,729 New	10,729 $118,000
Q2 2019 Aug 14, 2019	SELL	$4.9 - $9.31 $69,173 - $131,429	-14,117 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$4.26 - $6.86 $60,138 - $96,842	14,117 New	14,117 $74,000
Q1 2018 May 15, 2018	SELL	$8.71 - $14.82 $227,052 - $386,327	-26,068 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$7.8 - $12.94 $55,543 - $92,145	-7,121 Reduced 21.46%	26,068 $228,000
Q3 2017 Nov 14, 2017	BUY	$10.9 - $12.73 $361,760 - $422,495	33,189	33,189 $388,000

Others Institutions Holding SNDX

# of Institutions

229

Shares Held

88.4M

Call Options Held

1.01M

Put Options Held

692K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $774M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Syndax Pharmaceuticals Inc Transaction History